Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: INDUCTION CHEMOTHERAPY AND ECULIZUMAB TREATMENT OF HIGH-RISK MYELODYSPLASIA WITH A LARGE PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA CLONE. (September 2021)